Vascular Smooth Muscle Cells Express the Transcriptional Corepressor NAB2 in Response to Injury

Overview

Journal Am J Pathol

Publisher Elsevier

Specialty Pathology

Date 1999 Oct 9

PMID 10514413

Citations 19

Authors

E S Silverman

L M Khachigian

F S SANTIAGO

A J Williams

V Lindner

T Collins

Affiliations

Soon will be listed here.

Abstract

The early growth response 1 (Egr-1 or NGFI-A) gene product is a zinc finger protein transcription factor which has been implicated in the regulation of genes differentially expressed during the development of vascular disease. Egr-1 activity is regulated by alterations in the amount of protein, as well as protein-protein interactions with positive and negative transcriptional cofactors. NGFI-A-binding protein 2 (NAB2) is an example of a negative transcriptional cofactor capable of binding directly to Egr-1 and repressing Egr-1-mediated transcription. In this study, we show that NAB2 is rapidly and transiently expressed in vascular smooth muscle cells (VSMC) in response to the model agonist phorbol 12-myristate 13-acetate (PMA). This induction occurs at the protein as well as mRNA level, and the time course of induction trails closely behind that of Egr-1. NAB2 expression in VSMC is capable of inhibiting Egr-1 dependent gene expression in response to either PMA or fibroblastic growth factor-2 (FGF-2). In an in vivo model of mechanical arterial injury NAB2 levels also increase transiently in VSMC at a time when Egr-1 is elevated. It is possible that NAB2 is part of a negative-feedback mechanism which serves to down-regulate Egr-1-mediated gene transcription in injured VSMC.

Citing Articles

A promising nucleic acid therapy drug: DNAzymes and its delivery system.

Xiao L, Zhao Y, Yang M, Luan G, Du T, Deng S Front Mol Biosci. 2023; 10:1270101.

PMID: 37753371 PMC: 10518456. DOI: 10.3389/fmolb.2023.1270101.

A Comprehensive Review on Solitary Fibrous Tumor: New Insights for New Horizons.

Martin-Broto J, Mondaza-Hernandez J, Moura D, Hindi N Cancers (Basel). 2021; 13(12).

PMID: 34200924 PMC: 8230482. DOI: 10.3390/cancers13122913.

Dynamics of Protein Expression Reveals Primary Targets and Secondary Messengers of Estrogen Receptor Alpha Signaling in MCF-7 Breast Cancer Cells.

Drabovich A, Pavlou M, Schiza C, Diamandis E Mol Cell Proteomics. 2016; 15(6):2093-107.

PMID: 27067054 PMC: 5083091. DOI: 10.1074/mcp.M115.057257.

Egr-1 expression during neointimal development in flow-associated pulmonary hypertension.

Dickinson M, Bartelds B, Molema G, Borgdorff M, Boersma B, Takens J Am J Pathol. 2011; 179(5):2199-209.

PMID: 21924231 PMC: 3204093. DOI: 10.1016/j.ajpath.2011.07.030.

Time course analysis of gene expression identifies multiple genes with differential expression in patients with in-stent restenosis.

Ganesh S, Joo J, Skelding K, Mehta L, Zheng G, ONeill K BMC Med Genomics. 2011; 4:20.

PMID: 21356094 PMC: 3053213. DOI: 10.1186/1755-8794-4-20.

References

Gunther S, Alexander R, ATKINSON W, Gimbrone Jr M . Functional angiotensin II receptors in cultured vascular smooth muscle cells. J Cell Biol. 1982; 92(2):289-98. PMC: 2112084. DOI: 10.1083/jcb.92.2.289. View

SANTIAGO F, Atkins D, Khachigian L . Vascular smooth muscle cell proliferation and regrowth after mechanical injury in vitro are Egr-1/NGFI-A-dependent. Am J Pathol. 1999; 155(3):897-905. PMC: 1866910. DOI: 10.1016/S0002-9440(10)65189-9. View

Dignam J, Lebovitz R, Roeder R . Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983; 11(5):1475-89. PMC: 325809. DOI: 10.1093/nar/11.5.1475. View

Clowes A, Reidy M, Clowes M . Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. Lab Invest. 1983; 49(3):327-33. View

Milbrandt J . A nerve growth factor-induced gene encodes a possible transcriptional regulatory factor. Science. 1987; 238(4828):797-9. DOI: 10.1126/science.3672127. View

Sukhatme V, Cao X, Chang L, Tsai-Morris C, Stamenkovich D, Ferreira P . A zinc finger-encoding gene coregulated with c-fos during growth and differentiation, and after cellular depolarization. Cell. 1988; 53(1):37-43. DOI: 10.1016/0092-8674(88)90485-0. View

Kim S, Glick A, Sporn M, Roberts A . Characterization of the promoter region of the human transforming growth factor-beta 1 gene. J Biol Chem. 1989; 264(1):402-8. View

Verde P, Boast S, Franze A, Robbiati F, Blasi F . An upstream enhancer and a negative element in the 5' flanking region of the human urokinase plasminogen activator gene. Nucleic Acids Res. 1988; 16(22):10699-716. PMC: 338934. DOI: 10.1093/nar/16.22.10699. View

Lindner V, Lappi D, Baird A, Majack R, Reidy M . Role of basic fibroblast growth factor in vascular lesion formation. Circ Res. 1991; 68(1):106-13. DOI: 10.1161/01.res.68.1.106. View

10.

Lindner V, Reidy M . Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci U S A. 1991; 88(9):3739-43. PMC: 51528. DOI: 10.1073/pnas.88.9.3739. View

11.

Gashler A, Bonthron D, Madden S, Rauscher 3rd F, Collins T, Sukhatme V . Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1. Proc Natl Acad Sci U S A. 1992; 89(22):10984-8. PMC: 50467. DOI: 10.1073/pnas.89.22.10984. View

12.

Collins T . Endothelial nuclear factor-kappa B and the initiation of the atherosclerotic lesion. Lab Invest. 1993; 68(5):499-508. View

13.

Lindner V, Reidy M . Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study. Circ Res. 1993; 73(3):589-95. DOI: 10.1161/01.res.73.3.589. View

14.

Kramer B, Meichle A, Hensel G, Charnay P, Kronke M . Characterization of an Krox-24/Egr-1-responsive element in the human tumor necrosis factor promoter. Biochim Biophys Acta. 1994; 1219(2):413-21. DOI: 10.1016/0167-4781(94)90066-3. View

15.

Kilbourne E, Widom R, Harnish D, Malik S, Karathanasis S . Involvement of early growth response factor Egr-1 in apolipoprotein AI gene transcription. J Biol Chem. 1995; 270(12):7004-10. DOI: 10.1074/jbc.270.12.7004. View

16.

Gashler A, Sukhatme V . Early growth response protein 1 (Egr-1): prototype of a zinc-finger family of transcription factors. Prog Nucleic Acid Res Mol Biol. 1995; 50:191-224. DOI: 10.1016/s0079-6603(08)60815-6. View

17.

Russo M, Sevetson B, Milbrandt J . Identification of NAB1, a repressor of NGFI-A- and Krox20-mediated transcription. Proc Natl Acad Sci U S A. 1995; 92(15):6873-7. PMC: 41432. DOI: 10.1073/pnas.92.15.6873. View

18.

Khachigian L, Williams A, Collins T . Interplay of Sp1 and Egr-1 in the proximal platelet-derived growth factor A-chain promoter in cultured vascular endothelial cells. J Biol Chem. 1995; 270(46):27679-86. DOI: 10.1074/jbc.270.46.27679. View

19.

Cui M, Parry G, Oeth P, Larson H, Smith M, Huang R . Transcriptional regulation of the tissue factor gene in human epithelial cells is mediated by Sp1 and EGR-1. J Biol Chem. 1996; 271(5):2731-9. DOI: 10.1074/jbc.271.5.2731. View

20.

Khachigian L, Lindner V, Williams A, Collins T . Egr-1-induced endothelial gene expression: a common theme in vascular injury. Science. 1996; 271(5254):1427-31. DOI: 10.1126/science.271.5254.1427. View